Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Interactions in clinical trials: Protocol and statistical analysis plan for an explorative study of four randomized ICU trials on use of pantoprazole, oxygenation targets, haloperidol and intravenous fluids

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. AHA STEROID trial, dexamethasone in acute high-risk abdominal surgery, the protocol for a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Continuous monitoring of vital sign abnormalities; association to clinical complications in 500 postoperative patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diagnostic criteria of CNS infection in patients with external ventricular drainage after traumatic brain injury: a pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Development of a core outcome set for general intensive care unit patients - a protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Development of a core outcome set for general intensive care unit patients - a protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Early postoperative complications were common in non-ambulant paediatric patients with neuromuscular scoliosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Management of acute atrial fibrillation in the intensive care unit: An international survey

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Intensive care unit (ICU) patients receive numerous interventions, but knowledge about potential interactions between these interventions is limited. Co-enrolment in randomized clinical trials represents a unique opportunity to investigate any such interactions. We aim to assess interactions in four randomized clinical trials with overlap in inclusion periods and patient populations.

METHODS: This protocol and statistical analysis plan describes a secondary explorative analysis of interactions in four international ICU trials on pantoprazole, oxygenations targets, haloperidol and intravenous fluids, respectively. The primary outcome will be 90-day all-cause mortality. The secondary outcome will be days alive and out of hospital in 90 days after randomization. All patients included in the intention-to-treat populations of the four trials will be included. Four co-primary analyses will be conducted, one with each of the included trials as reference using a logistic regression model adjusted for the reference trial's stratification variables and for the co-interventions with interactions terms. The primary analytical measure of interest will be the analyses' tests of interaction. A p-value below .05 will be considered statically significant. The stratification variable- and co-intervention-adjusted effect estimates will be reported with 95% confidence intervals without adjustments for multiplicity.

CONCLUSION: This exploratory analysis will investigate the presence of any interactions between pantoprazole, oxygenation targets, haloperidol and amount of intravenous fluids in four international ICU trials using co-enrolment. Assessment of possible interactions represents valuable information to guide the design, statistical powering and conduct of future trials.

Original languageEnglish
JournalActa Anaesthesiologica Scandinavica
Volume66
Issue number1
Pages (from-to)156-162
Number of pages7
ISSN0001-5172
DOIs
Publication statusPublished - Jan 2022

Bibliographical note

© 2021 Acta Anaesthesiologica Scandinavica Foundation.

    Research areas

  • Critical Care, Haloperidol, Humans, Intensive Care Units, Pantoprazole, Treatment Outcome, drug interactions, critical illness, randomized controlled trials, intensive care units, pantoprazole, haloperidol, infusions, intravenous, pragmatic clinical trials, oxygen inhalation therapy

ID: 71675479